F-star Therapeutics, Inc.(NASDAQ:FSTX) 
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in...
Website: https://www.f-star.com
Founded: 2002
Full Time Employees: 84
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-09-09
P
O 6.50
H 6.58
L 6.43
C 6.49
V 93,685
10EMA 6.49
20EMA 6.49
60EMA 6.49
120EMA 6.49
250EMA 6.49